In a research report issued today, Deutsche Bank analyst Robyn Karnauskas downgraded shares of Aegerion Pharmaceuticals (NASDAQ:AEGR) to Hold from Buy and reduced her …
In a research report released yesterday, Janney Capital analyst Kimberly Lee reiterated a Buy rating on Aegerion Pharmaceuticals (AEGR) on the heels of …
In a research report released today, Janney Capital analyst Kimberly Lee maintained a Buy rating on Aegerion Pharmaceuticals (AEGR) with a $90 price target, which …